Insider Selling: Adtalem Global Education (NYSE:CVSA) CAO Sells $247,198.36 in Stock

Adtalem Global Education Inc. (NYSE:CVSA) CAO Manjunath Gangadharan sold 1,802 shares of the business’s stock in a transaction on Thursday, August 27th. The stock was sold at an average price of $137.18, for a total transaction of $247,198.36. Following the transaction, the chief accounting officer directly owned 5,083 shares of the company’s stock, valued at approximately $697,285.94. This represents a 26.17% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Price Performance

NYSE:CVSA opened at $134.71 on Monday. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.45. The firm’s fifty day moving average is $127.39. Adtalem Global Education Inc. has a one year low of $86.97 and a one year high of $156.26. The firm has a market cap of $4.59 billion, a PE ratio of 19.13, a P/E/G ratio of 1.00 and a beta of 0.62.

Adtalem Global Education (NYSE:CVSA) last posted its quarterly earnings results on Thursday, August 6th. The company reported $2.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.90 by $0.19. Adtalem Global Education had a net margin of 12.87% and a return on equity of 20.88%. The firm had revenue of $501.38 million for the quarter. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. As a group, equities research analysts anticipate that Adtalem Global Education Inc. will post 9 EPS for the current year.

Wall Street Analysts Forecast Growth

CVSA has been the topic of a number of research reports. Truist Financial upped their target price on shares of Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a research report on Monday, May 11th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Adtalem Global Education in a research report on Wednesday, August 19th. Barrington Research reiterated an “outperform” rating and set a $170.00 price objective on shares of Adtalem Global Education in a report on Monday, June 8th. Finally, Wall Street Zen upgraded shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $155.00.

Institutional Investors Weigh In On Adtalem Global Education

An institutional investor recently bought a new position in Adtalem Global Education stock. Kendall Capital Management purchased a new stake in Adtalem Global Education Inc. (NYSE:CVSA) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 11,622 shares of the company’s stock, valued at approximately $1,449,000. 98.84% of the stock is currently owned by institutional investors and hedge funds.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.